CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 4/A Open-market buy Director bought 3,709,819 shares at $10.50 ($38,953,100)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 25,800 shares at $15.97 ($411,995)
- 4 Open-market buy Chief Executive Officer bought 141,930 shares at an average $14.84 ($2,105,772)
- 4 Open-market buy Director bought 200,000 shares at $10.50 ($2,100,000)
Page 11 of 15 · 282 filings